This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Topamax Shows Mixed Results In Alcohol Dependence Study
A 14 week trial with 371 heavy drinkers found 15 percent on Topamax quit drinking entirely versus 3 percent on placebo. The study, at 17 U.S. sites, noted reduced daily drinks among completers but long-term relapse remains unclear. Researchers cited potential benefits and obstacles including patent expiry and off label use concerns.
MENTIONED IN THIS ARTICLE
Ortho-McNeil
Bankole Johnson
University of Virginia
U.S
Tom Wolfe
Earlysville
Wolfe
Willenbring
Topamax
Sidney Wolfe
Public Citizen’s Health Research Group
U.S. Food and Drug Administration